ロード中...
Aspects of prophylactic treatment of hemophilia
Retrospective and prospective studies unambiguously show that prophylactic treatment of severe hemophilia A or B should be started as primary prophylaxis at 1–2 years’ of age and ideally before the first joint bleed. The dose and dose frequency should be individually tailored depending on the goal o...
保存先:
| 出版年: | Thromb J |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056524/ https://ncbi.nlm.nih.gov/pubmed/27766056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-016-0103-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|